BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260518
DTEND;VALUE=DATE:20260521
DTSTAMP:20260514T224352
CREATED:20260128T093131Z
LAST-MODIFIED:20260128T093339Z
UID:42798-1779062400-1779321599@www.pharmajournalist.com
SUMMARY:7th TCR-Based Therapies Summit
DESCRIPTION:New assets have entered clinic\, whilst dozens more have been disclosed\, and recent investments such as\, T-Therapeutics’ $91M Series A extension to advance their bispecific towards the clinic and Anocca’s SEK 440M raise\, pinpoint how funding and portfolio decisions have the power to define the trajectory of the TCR field. \nIt is in this context that the 7th TCR-Based Therapies Summit returns to unite fellow biopharma experts in address shared challenges and to bridge the gap between promising clinical data and long-term\, commercially viable TCR-based approaches. \nAcross three focused days\, enter into open discussions\, benchmark with peers\, participate in practical problem-solving and hear new data in presentations led by Immunocore\, Enara Bio\, Regeneron\, Eureka Therapeutics\, T-Cypher Bio\, Zelluna Immunotherapy\, and Aethon Therapeutics. \nJoin us in empowering the community to shape a more durable\, scalable\, and commercially robust future for TCR-based therapies. \nTo know more visit: https://ter.li/uhpzx3
URL:http://www.pharmajournalist.com/event/7th-tcr-based-therapies-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR